MADE in America Act
HR 2707, the MADE in America Act, creates a 25-30% federal tax credit for manufacturers producing specific health products (including drugs, medical devices, personal protective equipment, and diagnostic tools) in designated "distressed zones." These zones are census tracts with over 30% poverty rates that are also designated as qualified opportunity zones. The credit applies to wages paid to employees working in these zones and qualified production costs (like equipment and materials), increasing to 30% if most employees reside locally. It directly affects pharmaceutical and medical device manufacturers operating in eligible low-income areas, aiming to incentivize domestic production of critical health products.
Bill status
in committee
1 of 4 stages cleared
Introduction
Apr 2023
Committee Review
Floor Vote
President
Introduced Apr 19, 2023
Last action Dec 17, 2024
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
3
Key actions
0
Committee
2
Dec 17, 2024
Committee
Referred to the Subcommittee on Health.
lower
Apr 19, 2023
Committee
Referred to the House Committee on Ways and Means.
lower
Apr 19, 2023
Introduced
Introduced in House
lower
1 primary · 13 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Earl L. "Buddy" Carter
RRepublican
Co
Carol D. Miller
RRepublican
Co
Darren Soto
DDemocratic
Co
Diana Harshbarger
RRepublican
Co
Eric A. "Rick" Crawford
RRepublican
Co
Gus M. Bilirakis
RRepublican
Co
H. Morgan Griffith
RRepublican
Co
Jefferson Van Drew
RRepublican
Co
John H. Rutherford
RRepublican
Co
Matt Cartwright
DDemocratic
Co
Nicholas A. Langworthy
RRepublican
Ask Maddy
·
AI policy assistant
Ask Maddy about HR 2707
Scope: US
Hi! I can help you understand HR 2707. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline